Table 2.
Application | Phase | Tumor Type | Patients | Adverse Effects | Outcome | Reference |
---|---|---|---|---|---|---|
Thermal ablation |
I | Recurrent glioblastoma |
3 |
|
Resolution of enhancement of treated volume in 2 of 3 patients |
Ram et al, 200622 |
I | Glioblastoma | 4 |
|
Limitations in device power prevented thermal coagulation |
McDannold et al, 201035 |
|
I/II | High grade glioma or brain metastasis |
Ongoing | - | - |
NCT01698437, NCT00147056, NCT01473485 |
|
Radiosensitization | I | Grade III astrocytoma and glioblastoma |
15 |
|
Target temperature achieved in 41.9% of measured regions |
Guthkelch et al, 199124 |
Sonodynamic therapy |
- | - | - | - | - | - |
Blood-brain barrier opening |
I | Glioblastoma | 1 | Unknownb | Blood-brain barrier opening confirmed with contrast enhancement on MRIb |
NCT02343991 |
Enhanced local delivery |
- | - | - | - | - | - |
Immunomodulation | - | - | - | - | - | - |
Intracranial hemorrhage occurred as a result of thermocouple probe placement, and was symptomatic in 2 cases.
Recruitment of additional patients is currently ongoing. Additional information is needed before comments regarding adverse effects and outcomes can be offered.